HC Wainwright Reiterates Buy Rating on CNTB with $7 Target
HC Wainwright continues to see upside in CNTB, maintaining its buy rating and $7 price target.
Key Points
- HC Wainwright reiterated its buy rating on CNTB with a $7 price target on June 25, 2026.
- HC Wainwright's $7 price target implies 219.63% upside from CNTB's ($CNTB) current $2.19 share price.
- Shares of CNTB traded at $2.12 on Thursday, reflecting the firm's positive outlook.
- Several firms, including Canaccord Genuity and Cantor Fitzgerald, have recently initiated buy ratings on CNTB.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 25, 2026, HC Wainwright reiterated its buy rating on CNTB, maintaining a price target of $7. This continued bullish stance suggests confidence in CNTB's potential for growth. Shares of CNTB traded at $2.12 on Thursday, providing potential upside as per HC Wainwright's analysis.
HC Wainwright & Co. vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in CNTB
Ikarian Capital, LLC increased its holdings in CNTB by 600,000 shares, bringing its total to 5,388,486 shares valued at about $13.1 million. Richmond Brothers, Inc. significantly boosted its position by 303,099 shares, now holding 476,584 shares worth approximately $1.25 million, marking a 174.7% increase. Meanwhile, 683 Capital Management, LLC opened a new position with 900,000 shares valued at $2.36 million, and Adar1 Capital Management, LLC also initiated a stake with 742,400 shares valued at $1.95 million.
Insider Buying and Selling at CNTB
Recent insider activity includes a purchase by James Huang of 150,000 shares at an average price of $2.48 on May 29, 2026. Earlier in the year, Jean Liu and Kleanthis Gabriel Xanthopoulos acquired 5,061 and 2,816 shares respectively on March 31, 2026. On the selling side, Panacea Innovation Limited sold 2,000,000 shares at $3.00 on November 24, 2025, and Wei Zheng sold 650,000 shares at $3.19 on November 21, 2025.
Analysts Set New Price Targets
On June 25, 2026, HC Wainwright & Co. reiterated its buy rating on CNTB with a $7 price target. Canaccord Genuity initiated coverage with a buy rating and a $6 target on May 26, 2026. Cantor Fitzgerald also started coverage with a buy rating, setting a $4 target on May 21, 2026. Earlier, BTIG reiterated its buy rating with a $10 target on March 31, 2026. The consensus among analysts remains positive, with a buy recommendation and a mean target price reflecting optimism about CNTB's future.
Bottom Line
CNTB continues to attract positive attention from analysts, with HC Wainwright reiterating a buy rating and setting a $7 price target. As shares traded at $2.12 on Thursday, the potential for appreciation remains significant. Institutional investors have been active, with several funds increasing their stakes or opening new positions. These actions reflect a general optimism about CNTB's prospects, though it's important for investors to remember that 13F filings and analyst ratings are backward-looking and may not reflect the most current market conditions.
Get CNTB alerts
New 13F filings, insider trades, and analyst moves on $CNTB, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.